Dr. Ciara Kelly of Memorial Sloan Kettering Cancer Center at presented The Role of ctDNA in GIST at New Horizons 2019 in Wayne, NJ.
The presentation "Interventional Radiology Approaches to Treat Recurrent GIST" was given at New Horizons 2019 in Wayne, NJ by Dr. Joseph Erinjeri of Memorial Sloan Kettering Cancer Center.
This video is of Rodrigo Salas of Fundación GIST México presenting Real World Evidence at New Horizons 2019 in Wayne, NJ.
LRG volunteers not only expand our reach and services to patients and caregivers but also help us increase GIST awareness to the general public and funding towards GIST research.
Understanding the Concept of "Precision Oncology" in patient-friendly language presented by Dr. Jason Sicklick of Moores Cancer Center UCSD at New Horizons 2019.
The LRG, in collaboration with the Pediatric & SDH-Deficient GIST Consortium and key opinion leaders among the GIST pathology community (with Dr. Brian Rubin taking the lead), played a significant role in changing CAP Guidelines. CAP Guidelines are protocols for pathologists to instruct them on the process of diagnosing a disease based on tumor tissue samples.
This webcast was originally recorded May 21, 2019. Follow this link for webcast with Hebrew Subtitles. Listen to the webcast - Hebrew subtitles Are you interested in optimizing your treatment? In [...]
The FDA granted the approval of Rozlytrek™ (entrectnib) for the treatment of adults with ROS1-positive, metastatic non-small cell lung cancer (NSCLC), The FDA has also granted accelerated approval to Rozlytrek for the treatment of [...]
Most GIST patients will see a surgeon at some point during their treatment. This webcast will address the issues surrounding the decision to have an operation and considers that surgical options depend on a number of factors such as tumor location, tumor size, tumor number, response to drug therapy, and risk of recurrence.
Deciphera Pharmaceuticals has released positive results from their INVICTUS Phase 3 Clinical Study of Ripretinib in patients with GIST. They have also updated results from the Phase 1 Study. Deciphera shared that "patients treated [...]